Preservation of allergic contact dermatitis to poison ivy (Urushiol) in late HIV disease - The implications and relevance to immunotherapy with contact allergens

被引:9
作者
Smith, KJ
Skelton, HG
Nelson, A
Wagner, KF
Hackley, BE
机构
[1] USA, MED RES INST CHEM DEF, ABERDEEN, MD USA
[2] ARMED FORCES INST PATHOL, WASHINGTON, DC 20306 USA
关键词
Urushiol; HIV disease; immunotherapy; allergic contact dermatitis;
D O I
10.1159/000245718
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Delayed hypersensitivity reactions (DTH) are lost with progression of HIV disease, This loss of DTH commonly occurs before the onset of opportunistic infections and is an independent predictor of disease progression, Objective: We wanted to determine whether patients in late HIV disease with a history of allergic contact dermatitis (ACD) to poison ivy continue to react to poison ivy, Methods: Twelve HIV+ patients with a past history of ACD to poison ivy were tested with an extract prepared from poison ivy leaves, All but 1 patient had CD4+ T cell counts <200/mu l, and 5 patients had had an opportunistic infection. Results: All 12 patients showed positive reactions ranging from mild erythema and infiltration to marked erythema with bulla formation, Conclusions: ACD is considered a variant of DTH, and as DTH results in a T helper 1 cytokine pattern. However, the antigen-specific effector cells in ACD may be more diverse than in DTH. This diversity could explain the continued reaction to some contact allergens in late disease and may be important in the use of contact allergens for immunotherapy.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 26 条
[1]  
ASCHER MS, 1990, J ACQ IMMUN DEF SYND, V3, P177
[2]   TH1 AND TH2 CYTOKINE PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HIV-INFECTED PATIENTS [J].
BARCELLINI, W ;
RIZZARDI, GP ;
BORGHI, MO ;
FAIN, C ;
LAZZARIN, A ;
MERONI, PL .
AIDS, 1994, 8 (06) :757-762
[3]  
BIRX DL, 1993, J ACQ IMMUN DEF SYND, V6, P1248
[4]  
BLAUVELT A, 1995, J INVEST DERMATOL, V105
[5]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[6]   PREVALENCE AND CLINICAL SPECTRUM OF SKIN-DISEASE IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
COLDIRON, BM ;
BERGSTRESSER, PR .
ARCHIVES OF DERMATOLOGY, 1989, 125 (03) :357-361
[7]   CD30, TH2 CYTOKINES AND HIV-INFECTION - A COMPLEX AND FASCINATING LINK [J].
DELPRETE, G ;
MAGGI, E ;
PIZZOLO, G ;
ROMAGNANI, S .
IMMUNOLOGY TODAY, 1995, 16 (02) :76-80
[8]   POTENTIAL HAZARDS OF DINITROCHLOROBENZENE (DNCB) DISPUTED [J].
DUNAGIN, WG .
ARCHIVES OF DERMATOLOGY, 1986, 122 (01) :11-12
[9]  
ENK AH, 1993, J IMMUNOL, V151, P2390
[10]  
Epstein W. L., 1995, American Journalof Contact Dermatitis, V6, P117, DOI [10.1016/1046-199X(95)90111-6, DOI 10.1016/1046-199X(95)90111-6]